| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Mohamed A Yassin | Q90558738 |
| P2093 | author name string | Ashraf T Soliman | |
| Heba Elsedfy | |||
| Vincenzo De Sanctis | |||
| Salvatore Di Maio | |||
| Christos Kattamis | |||
| Shahina Daar | |||
| Giuseppe Raiola | |||
| Duran Canatan | |||
| Joan-Lluis Vives Corrons | |||
| P2860 | cites work | Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography | Q93216314 |
| Thyrotropin-releasing hormone | Q93857362 | ||
| Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges | Q22306204 | ||
| Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum | Q24628836 | ||
| Reporting Thyroid Function Tests in Pregnancy | Q26768622 | ||
| Thyroid function in pregnancy: what is normal? | Q27008509 | ||
| Bone disease in thyrotoxicosis | Q27022238 | ||
| Management of subclinical hypothyroidism in pregnancy: are we too simplistic? | Q28081018 | ||
| Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C. | Q30469296 | ||
| Thyroid hormone and the cardiovascular system | Q31921377 | ||
| Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major | Q33624875 | ||
| Beta-thalassaemia intermedia: evaluation of endocrine and bone complications | Q33943025 | ||
| 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. | Q33944124 | ||
| Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease | Q34117896 | ||
| The effects of amiodarone on the thyroid | Q34213782 | ||
| Cranial irradiation and central hypothyroidism | Q34221244 | ||
| Cardiomyopathy and pericardial effusion in a 7 year-old boy with beta-thalassaemia major, severe primary hypothyroidism and hypoparathyroidism due to iron overload. | Q46066261 | ||
| Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study | Q46066265 | ||
| Exaggerated TSH response to TRH ("sub-biochemical" hypothyroidism) in prepubertal and adolescent thalassaemic patients with iron overload: prevalence and 20-year natural history. | Q46066267 | ||
| The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial | Q46640989 | ||
| Pituitary iron and volume imaging in healthy controls. | Q46781383 | ||
| Serum leptin, insulin-like growth factor-I components and sex-hormone binding globulin. Relationship with sex, age and body composition in healthy population | Q46980866 | ||
| Serum ferritin in the diagnosis of cardiac and liver iron overload in thalassaemia patients real-world practice: a multicentre study. | Q48099529 | ||
| Growth Hormone (GH) and Cardiovascular System | Q48218551 | ||
| Pathophysiology and treatment of patients with beta-thalassemia - an update. | Q48247015 | ||
| Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. | Q48359254 | ||
| Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta-thalassemic patients. | Q48382982 | ||
| Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients | Q48497652 | ||
| Hypothalamus-Pituitary-Thyroid Axis. | Q48653909 | ||
| Papillary thyroid cancer in thalassaemia. | Q50789161 | ||
| High prevalence of central hypothyroidism in adult patients with β-thalassemia major. | Q50799584 | ||
| Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement | Q34556507 | ||
| The hypothalamus-pituitary-thyroid axis in critical illness. | Q35013013 | ||
| Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia | Q35528614 | ||
| Estimating tissue iron burden: current status and future prospects | Q35793545 | ||
| Assessment of thyroid function in children aged 1-13 years with Beta-thalassemia major | Q36244654 | ||
| Anti-Thyroid Peroxidase Antibodies and Male Gender Are Associated with Diabetes Occurrence in Patients with Beta-Thalassemia Major | Q36795517 | ||
| Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines | Q36862278 | ||
| Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center | Q37015578 | ||
| Links between thyroid hormone action, oxidative metabolism, and diabetes risk? | Q37085967 | ||
| Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literature | Q37107477 | ||
| Thyroid hormones and aging | Q37116522 | ||
| Thyroid function in major thalassemia patients: Is it related to height and chelation therapy? | Q37155782 | ||
| Mechanisms related to the pathophysiology and management of central hypothyroidism | Q37305405 | ||
| Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: experience at a tertiary care centre in oman. | Q37400220 | ||
| Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years | Q37413963 | ||
| Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran. | Q37522170 | ||
| Effects of amiodarone therapy on thyroid function | Q37638158 | ||
| Amiodarone and thyroid | Q37639657 | ||
| Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature. | Q37907312 | ||
| Thyroid hormones and the heart | Q38267475 | ||
| Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5'-flanking region of the PKC-beta gene in the response to ferric transferrin. | Q38302469 | ||
| Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force | Q38792700 | ||
| The effects of oestrogens and their receptors on cardiometabolic health | Q38901474 | ||
| Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. | Q39222504 | ||
| Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia | Q39561372 | ||
| Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). | Q40352608 | ||
| Thyrotropin-releasing hormone-stimulated thyrotropin expression involves islet-brain-1/c-Jun N-terminal kinase interacting protein-1. | Q40519467 | ||
| Assessment of thyroid function in two hundred patients with beta-thalassemia major | Q40650430 | ||
| Viruses and cancers: possible role of hepatitis C virus | Q41628057 | ||
| Impaired response of free alpha-subunits after luteinizing hormone-releasing hormone and thyrotropin-releasing hormone stimulations in beta-thalassemia major | Q42505351 | ||
| Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state | Q43185271 | ||
| Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major | Q43242677 | ||
| Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major | Q43934420 | ||
| Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. | Q44472085 | ||
| Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients | Q44720610 | ||
| Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy | Q44804688 | ||
| The impact of genotype on endocrine complications in thalassaemia major | Q44806483 | ||
| European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. | Q44808015 | ||
| Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related? | Q45385185 | ||
| New therapeutic targets in transfusion-dependent and -independent thalassemia. | Q45875628 | ||
| Papillary thyroid microcarcinoma in thalassaemia: an emerging concern for physicians? | Q51194266 | ||
| Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications. | Q51469778 | ||
| Longitudinal study on thyroid function in patients with thalassemia major. | Q51769368 | ||
| Thyroid Function in Chronically Transfused Children with Beta Thalassemia Major: A Cross-Sectional Hospital Based Study | Q57300296 | ||
| The effect of levothyroxine treatment on left ventricular function in subclinical hypothyroidism | Q57300982 | ||
| Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience | Q58127307 | ||
| A new ultrasound nomogram for differentiating benign and malignant thyroid nodules | Q58613842 | ||
| Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis | Q60951670 | ||
| New frontiers in the therapeutic approach of patients with cardiovascular and endocrine diseases | Q64041545 | ||
| TRH Neurons and Thyroid Hormone Coordinate the Hypothalamic Response to Cold. | Q64984352 | ||
| Sonographic diagnosis and grading of Hashimoto's thyroiditis | Q68243080 | ||
| Total sleep deprivation and the thyroid axis: effects of sleep and waking activity | Q71580367 | ||
| Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism | Q73049130 | ||
| Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes | Q73416479 | ||
| Central hypothyroidism | Q81093715 | ||
| Frequency of hypothyroidism in patients of beta-thalassaemia | Q82423737 | ||
| Ultrasound thyroid evaluation in thalassemic patients: correlation between the aspects of thyroidal stroma and function | Q82488085 | ||
| β-thalassemia and thyroid failure: is there a role for thyroid autoimmunity? | Q84448412 | ||
| Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline | Q84744488 | ||
| Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major | Q85266398 | ||
| Chronic anemia and thyroid function | Q87984514 | ||
| Thyroid Disorders and Hemostasis | Q90470540 | ||
| Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes | Q90613185 | ||
| Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function | Q90847730 | ||
| An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations | Q91107003 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | e2019029 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | Mediterranean journal of hematology and infectious diseases | Q27723406 |
| P1476 | title | Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems | |
| P478 | volume | 11 |
Search more.